A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Remdesivir is a broad-spectrum antiviral medication (nucleoside analogue) that was originally developed to counter Hepatitis C and was then repurposed for use against different viral diseases and infections. Like most direct-acting antivirals it works by blocking a virus’ RNA polymerase and prevent it from replicating its genetic material. This makes it so the virus is not able to grow in quantity and create more in the way of effects on the patient’s health.
One of the primary advantages is that it will not affect the infected cells itself and will only prevent the virus from being able to copy itself. As of July 2020, clinical trials for Remdesivir were still ongoing.
Remdesivir is an injected medication that is used to speed recovery of individuals suffering from RNA viruses, and the most well known of these in recent times due to their prominence have been the SARS and MERS coronaviruses along with COVID-19. It has been reported to reduce recovery times by up to 30% for these viral infections or diseases. 2020 has seen it been aggressively pursued as a potential solution for the COVID-19 pandemic.
Use of Remdesivir may cause patients to experience any of the following side effects:
Remdesivir is sold under the brand name Veklury, and in July 2020 was approved by the US FDA for emergency use as a COVID-19 treatment.